14
Role of Computer in Drug Design PRESENTED BY:-ANKIT TIWARI

Role of computers in drug design1

Embed Size (px)

DESCRIPTION

This ppt had covered important points and terms related to the role of computer in drug design....

Citation preview

Page 1: Role of computers in drug design1

Role of Computer in Drug Design

PRESENTED BY:-ANKIT TIWARI

Page 2: Role of computers in drug design1

PRESESNTED BY

Page 3: Role of computers in drug design1

Drug Design / drug discovery

What’s a drug? A substance that treats/cure a disease.A small molecule that interacts with a target, (often protein involved in the disease process; activator/inhibitor)

Drug discovery:The process of finding such a small molecule – combination of approaches

Drug discovery or drug design? In principle: “Design” is more rational and targeted, and “discovery” is more serendipitous. But design and discovery share a lot and are ~ synonymous in a pharmaceutical context.

Page 4: Role of computers in drug design1

Gigantic economic importance: 10 years & $200 to $1,900 million to develop a drug25 new molecules /year

Intense scientific activity: very interdisciplinary approach> $340 billion

Drug discovery market

in millions US$ Revenue R&D income

Johnson & Johnson 53,324 7,125 11,053

Pfizer 48,371 7,599 19,337

GlaxoSmithKline 42,813 6,373 10,135

Novartis 37,020 5,349 7,202

Sanofi-Aventis 35,645 5,565 5,033

Hoffmann–La Roche 33,547 5,258 7,318

AstraZeneca 26,475 3,902 6,063

Merck & Co. 22,636 4,783 4,434

Abbott Laboratories 22,476 2,255 1,717

Wyeth 20,351 3,109 4,197

http://en.wikipedia.org/wiki/List_of_pharmaceutical_companies

Page 5: Role of computers in drug design1

Chemistry: synthesis

Discovery and design (hit/lead/optimisation)

Biology: assay (binding/activity; in vitro / in vivo,)

Target identification

The drug discovery and design workflow:

drug development:Pharmacology / testing

Page 6: Role of computers in drug design1

The long and winding road to drug discovery

Computational chemistry /Molecular modeling

useful across the pipeline, but

very different techniques

aim for success,but if not:

fail early, fail cheap

Page 7: Role of computers in drug design1

Role of Computers

• In early 90’s there was a deal of optimism that computer’s will play a major role in the improvement of drug design.

• It reduced at-least 5 year’s of research duration.

Page 8: Role of computers in drug design1

Computer aided drug design(CADD)

• Computer aided drug design is a specialized discipline that uses computational methods to stimulate drug receptor interactions.

• CADD technique are dependent on bioinformatics tools, databases & applications.

Page 9: Role of computers in drug design1

What is QSAR?

• QSAR depict an attempt to correlate structural property of compounds with biological activities.

• Such developments have provided a sound basis for the generation of 3D Quantitative Structure Activity Relationship (QSAR) for further refinement of the ligand molecule in terms of chemical structure so as to improve biological activity.

• Such physiochemical descriptors which indulge parameters to account for hydrophobicity, electronic properties, steric effects, etc. can be determined by computational methods.

Page 10: Role of computers in drug design1

Bioinformatics

Page 11: Role of computers in drug design1

Structure-basedknow receptor,don’t known ligands

Two pathways to drug discovery / drug design

?What will be happy in there?

Structure-baseddon’t know receptor,known ligands

Protein/ligand interactionsstructure/biophysicsdocking

Statistical analysis of what group(s) are important for biological activity

Page 12: Role of computers in drug design1

Receptor interaction

Page 13: Role of computers in drug design1

Structure based

Uses protein structure directlyCADD: Protein-ligand docking

Page 14: Role of computers in drug design1

Ligand based

• Binding of ligand to the receptor may include hydrophobic, electrostatic and hydrogen bonding interactions.-Derive information from ligand structures-Protein structure not always available

• 40% of all prescription pharmaceuticals target GPCRs-Protein structure has large degree of flexibility

• Structure deforms to accommodate ligands or gross movements occur on binding